ntera2 Search Results


95
ATCC human tgct embryonal carcinoma ec cell lines nt2 d1
Human Tgct Embryonal Carcinoma Ec Cell Lines Nt2 D1, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tgct embryonal carcinoma ec cell lines nt2 d1/product/ATCC
Average 95 stars, based on 1 article reviews
human tgct embryonal carcinoma ec cell lines nt2 d1 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

96
ATCC nt2 cells
Nt2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nt2 cells/product/ATCC
Average 96 stars, based on 1 article reviews
nt2 cells - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

93
DSMZ ntera 2 nt2 cell line
Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of <t>NT2</t> cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.
Ntera 2 Nt2 Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera 2 nt2 cell line/product/DSMZ
Average 93 stars, based on 1 article reviews
ntera 2 nt2 cell line - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology nt2 cells
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Nt2 Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nt2 cells/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
nt2 cells - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

90
Federation of European Neuroscience Societies ntera-2 cells
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Ntera 2 Cells, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera-2 cells/product/Federation of European Neuroscience Societies
Average 90 stars, based on 1 article reviews
ntera-2 cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
DS Pharma Biomedical ntera-2
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Ntera 2, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera-2/product/DS Pharma Biomedical
Average 90 stars, based on 1 article reviews
ntera-2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
DWK Life Sciences ntera2!2102ep hybrid line, c10
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Ntera2!2102ep Hybrid Line, C10, supplied by DWK Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera2!2102ep hybrid line, c10/product/DWK Life Sciences
Average 90 stars, based on 1 article reviews
ntera2!2102ep hybrid line, c10 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Layton BioScience ntera2/d1 cells
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Ntera2/D1 Cells, supplied by Layton BioScience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera2/d1 cells/product/Layton BioScience
Average 90 stars, based on 1 article reviews
ntera2/d1 cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Brookhaven Instruments ntera2 cells
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Ntera2 Cells, supplied by Brookhaven Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera2 cells/product/Brookhaven Instruments
Average 90 stars, based on 1 article reviews
ntera2 cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Illumina Inc diploid pluripotent ec cell line ntera2
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Diploid Pluripotent Ec Cell Line Ntera2, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/diploid pluripotent ec cell line ntera2/product/Illumina Inc
Average 90 stars, based on 1 article reviews
diploid pluripotent ec cell line ntera2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
European Collection of Authenticated Cell Cultures ntera-2 clone d1
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Ntera 2 Clone D1, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera-2 clone d1/product/European Collection of Authenticated Cell Cultures
Average 90 stars, based on 1 article reviews
ntera-2 clone d1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
LGC Promochem ntera2/cl.d1 (nt2) fibroblast cells
( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of <t>NT2</t> cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).
Ntera2/Cl.D1 (Nt2) Fibroblast Cells, supplied by LGC Promochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ntera2/cl.d1 (nt2) fibroblast cells/product/LGC Promochem
Average 90 stars, based on 1 article reviews
ntera2/cl.d1 (nt2) fibroblast cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of NT2 cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.

Journal: Scientific reports

Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.

doi: 10.1038/s41598-024-52675-3

Figure Lengend Snippet: Figure 1. In-silico analysis of GPM6B expression. (a) Across several primates, the expression of GPM6B was at its highest level in the human brain. (b) Our analysis of the RNA-seq datasets retrieved from GEO showed a positive correlation between GPM6B and neural cell differentiation markers, such as GFAP, TUBB3, and MAP2, after differentiation of NT2 cells into neural cells (21 days under RA treatment). HUM, human; CHP, chimpanzee; OWM, Old-World monkeys; NWM, New-World monkeys; MLM, mouse lemur.

Article Snippet: NTERA-2 (NT2) cell line (Cat. #ACC-527, RRID:CVCL_0034; was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures GmbH), resembling characteristics of human neuronal progenitor cell, Figure 4.

Techniques: In Silico, Expressing, RNA Sequencing, Cell Differentiation

Figure 3. Measuring the expression level of the edited GPM6B gene at the RNA and protein levels in NT2 cells. (a) The expression level of GPM6B was evaluated in the untreated and edited NT2 pool cells, using qRT-PCR. The expression level of GPM6B decreased significantly in the edited pool cells (p < 0.05). (b) The expression of GPM6B was assessed in the isolated single clones, using qRT-PCR. The expression of GPM6B was significantly decreased in the C1 cells, compared to the untreated and the SC3 cells. (c) Western blotting assay confirmed that the expression level of GPM6B was decreased in the C1 cells more efficiently, compared to the untreated and SC3 cells. The original blot images are presented in Supplementary Fig. Xd. (d) the predicted TF binding sites at GA-repeat site and its flanking sequence, is presented based on JASPAR CORE 2022 and ChIP-seq data from ENCODE. The GA-repeat site is highlighted with light blue.

Journal: Scientific reports

Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.

doi: 10.1038/s41598-024-52675-3

Figure Lengend Snippet: Figure 3. Measuring the expression level of the edited GPM6B gene at the RNA and protein levels in NT2 cells. (a) The expression level of GPM6B was evaluated in the untreated and edited NT2 pool cells, using qRT-PCR. The expression level of GPM6B decreased significantly in the edited pool cells (p < 0.05). (b) The expression of GPM6B was assessed in the isolated single clones, using qRT-PCR. The expression of GPM6B was significantly decreased in the C1 cells, compared to the untreated and the SC3 cells. (c) Western blotting assay confirmed that the expression level of GPM6B was decreased in the C1 cells more efficiently, compared to the untreated and SC3 cells. The original blot images are presented in Supplementary Fig. Xd. (d) the predicted TF binding sites at GA-repeat site and its flanking sequence, is presented based on JASPAR CORE 2022 and ChIP-seq data from ENCODE. The GA-repeat site is highlighted with light blue.

Article Snippet: NTERA-2 (NT2) cell line (Cat. #ACC-527, RRID:CVCL_0034; was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures GmbH), resembling characteristics of human neuronal progenitor cell, Figure 4.

Techniques: Expressing, Quantitative RT-PCR, Isolation, Clone Assay, Western Blot, Binding Assay, Sequencing, ChIP-sequencing

Figure 5. Disrupted differentiation of NT2 cells to astrocytic and neural cells as a result of GA-repeat deletion and GPM6B downregulation. Deletion of the GA-repeat in the regulatory region of GPM6B decreased the expression of this gene. Consequently, the number of differentiated cells expressing GFAP, TUBB3, and MAP2 decreased significantly in the C1 compared to the SC3 cells.

Journal: Scientific reports

Article Title: CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells.

doi: 10.1038/s41598-024-52675-3

Figure Lengend Snippet: Figure 5. Disrupted differentiation of NT2 cells to astrocytic and neural cells as a result of GA-repeat deletion and GPM6B downregulation. Deletion of the GA-repeat in the regulatory region of GPM6B decreased the expression of this gene. Consequently, the number of differentiated cells expressing GFAP, TUBB3, and MAP2 decreased significantly in the C1 compared to the SC3 cells.

Article Snippet: NTERA-2 (NT2) cell line (Cat. #ACC-527, RRID:CVCL_0034; was purchased from DSMZ-German Collection of Microorganisms and Cell Cultures GmbH), resembling characteristics of human neuronal progenitor cell, Figure 4.

Techniques: Expressing

( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of NT2 cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).

Journal: eLife

Article Title: Serotonin signaling by maternal neurons upon stress ensures progeny survival

doi: 10.7554/eLife.55246

Figure Lengend Snippet: ( A ) Experimental setup for assessing whether 5-HT is a conserved signal that activates HSF1 in mammalian cells. ( B, C ) Time and dose-dependent change in Hspb1 and Hspb5 mRNA levels respectively, in control and 5-HT-treated primary cortical neuronal cultures (n = 4 experiments). ( D ) Representative western blot showing HSPA1A protein levels following 5-HT stimulation of NT2 cells (5 µM was applied for 24 hr to be able to assess protein accumulation; n = 4 experiments). ( E ) Quantitation of HSPA1A protein levels in control and 5-HT treated NT2 cells (n = 3 experiments). Tubulin was used as internal control. ( F ) Representative western blot showing HSF1 protein levels in control and HSF1 siRNA-treated NT2 cells to confirm siRNA knockdown of HSF1 (n = 2 experiments). ( G ) Temporal dynamics of HSPA1A mRNA levels in control and BIMU8-treated NT2 cells (n = 5 experiments). ( H ) HSPA1A mRNA levels in untreated and BIMU8-treated NT2 cells (10 µM for 10 min) transfected with control and HSF-1 siRNA (n = 4 experiments). ( I ) Hspa1 and Hspb1 mRNA levels in untreated and BIMU8-treated (10 µM for 10 min) primary cortical neuronal cultures (n = 3 experiments). ( J ) Quantitation of fluorescence intensity following immunostaining for HSF1 in the nuclei of untreated NT2 cells, NT2 cells treated with BIMU8 (10 µM for 10 min), and NT2 cells treated with BIMU8 and H89. Fluorescence intensity values (arbitrary units) were derived using ImageJ following background subtraction and normalized to that in control untreated cells. (n = 2 experiments; 25 cells each). ( K ) SUPT16H mRNA levels in control-siRNA and SUPT16H- siRNA treated NT2 cells to confirm siRNA knockdown of SUPT16H (n = 5 experiments). Data in B, C, E, G-K show Mean ± Standard Error of the Mean. Values were normalized to that in either control untreated cells, or control-siRNA treated cells. *, p<0.05; **, p<0.01 ***, p<0.001; (paired Students t-test).

Article Snippet: Control siRNA and siRNA targeting human HSF1 and SUPT16H (SPT16) were procured from Santa Cruz Biotechnology Inc, USA (catalog no. sc-37007, sc-35611 and sc-37875 respectively) and NT2 cells were transfected with Lipofectamine LTX Plus reagent according to manufacturer’s protocol.

Techniques: Control, Western Blot, Quantitation Assay, Knockdown, Transfection, Fluorescence, Immunostaining, Derivative Assay

( A ) Time and dose-dependent change in Hspa1a mRNA levels in control and 5-HT treated primary cortical neuronal cultures (n = 4 experiments). ( B ) Dose-dependent change in HSPA1A mRNA levels in control NT2 cells and NT2 cells treated with 5-HT for 15 min (n = 4 experiments). ( C ) HSPA1A mRNA levels in NT2 cells treated with 5 µM 5-HT for 15 min, transfected with control and HSF1 siRNA (n = 4 experiments). ( D ) HSPA1A mRNA levels in NT2 cells treated with two different doses of four 5-HT receptor agonists relative to control untreated cells (n = 5 experiments). NT2 cells were treated for 10 min. ( E–F ) Protein levels of S320 phospho-modified HSF1 in control NT2 cells and cells treated with 10 µM BIMU8 for 10 min, in the presence or absence of the PKA inhibitor, H89 (n = 4 experiments). ( E ) Representative western blot using an antibody that recognizes HSF1 phosphorylated at S320. Tubulin served as the internal control. ( F ) Quantitation of phospho-S320 levels (n = 4 experiments). ( G ) Representative micrographs showing projections of confocal images of HSF1 localization in control NT2 cells and cells treated with 10 µM BIMU8 for 10 min, in the presence or absence of the H89 (n = 2 experiments; 25 cells). Scale bar = 10 µm. ( H ) HSPA1A mRNA levels relative to control NT2 cells upon treatment with 10 µM BIMU8 for 10 min, in the presence or absence of H89 (n = 5 experiments). ( I ) HSPA1A mRNA levels in cells treated with 10 µM BIMU8 for 10 min, transfected with control and SUPT16H siRNA. mRNA levels and protein levels are normalized to control RNAi-treated or unstimulated cells (n = 5 experiments). Data in A-D, F, H, I show Mean ± Standard Error of the Mean. *, p<0.05; **, p<0.01 ***, p<0.001; (Paired Student’s t-test). ns, non-significant.

Journal: eLife

Article Title: Serotonin signaling by maternal neurons upon stress ensures progeny survival

doi: 10.7554/eLife.55246

Figure Lengend Snippet: ( A ) Time and dose-dependent change in Hspa1a mRNA levels in control and 5-HT treated primary cortical neuronal cultures (n = 4 experiments). ( B ) Dose-dependent change in HSPA1A mRNA levels in control NT2 cells and NT2 cells treated with 5-HT for 15 min (n = 4 experiments). ( C ) HSPA1A mRNA levels in NT2 cells treated with 5 µM 5-HT for 15 min, transfected with control and HSF1 siRNA (n = 4 experiments). ( D ) HSPA1A mRNA levels in NT2 cells treated with two different doses of four 5-HT receptor agonists relative to control untreated cells (n = 5 experiments). NT2 cells were treated for 10 min. ( E–F ) Protein levels of S320 phospho-modified HSF1 in control NT2 cells and cells treated with 10 µM BIMU8 for 10 min, in the presence or absence of the PKA inhibitor, H89 (n = 4 experiments). ( E ) Representative western blot using an antibody that recognizes HSF1 phosphorylated at S320. Tubulin served as the internal control. ( F ) Quantitation of phospho-S320 levels (n = 4 experiments). ( G ) Representative micrographs showing projections of confocal images of HSF1 localization in control NT2 cells and cells treated with 10 µM BIMU8 for 10 min, in the presence or absence of the H89 (n = 2 experiments; 25 cells). Scale bar = 10 µm. ( H ) HSPA1A mRNA levels relative to control NT2 cells upon treatment with 10 µM BIMU8 for 10 min, in the presence or absence of H89 (n = 5 experiments). ( I ) HSPA1A mRNA levels in cells treated with 10 µM BIMU8 for 10 min, transfected with control and SUPT16H siRNA. mRNA levels and protein levels are normalized to control RNAi-treated or unstimulated cells (n = 5 experiments). Data in A-D, F, H, I show Mean ± Standard Error of the Mean. *, p<0.05; **, p<0.01 ***, p<0.001; (Paired Student’s t-test). ns, non-significant.

Article Snippet: Control siRNA and siRNA targeting human HSF1 and SUPT16H (SPT16) were procured from Santa Cruz Biotechnology Inc, USA (catalog no. sc-37007, sc-35611 and sc-37875 respectively) and NT2 cells were transfected with Lipofectamine LTX Plus reagent according to manufacturer’s protocol.

Techniques: Control, Transfection, Modification, Western Blot, Quantitation Assay

Journal: eLife

Article Title: Serotonin signaling by maternal neurons upon stress ensures progeny survival

doi: 10.7554/eLife.55246

Figure Lengend Snippet:

Article Snippet: Control siRNA and siRNA targeting human HSF1 and SUPT16H (SPT16) were procured from Santa Cruz Biotechnology Inc, USA (catalog no. sc-37007, sc-35611 and sc-37875 respectively) and NT2 cells were transfected with Lipofectamine LTX Plus reagent according to manufacturer’s protocol.

Techniques: CRISPR, Sequencing, Control, cDNA Synthesis, SYBR Green Assay, DNA Purification, Software, Fluorescence, Imaging